HOME >> MEDICINE >> NEWS
Heart failure medication does not improve survival, compared to more widely used medication

The drug levosimendan did not improve survival for patients with decompensated heart failure when compared with a more widely-used treatment for this condition, dobutamine, according to a study in the May 2 issue of JAMA.

Acute decompensated heart failure (ADHF; severe heart failure characterized by inability of the heart to maintain adequate blood circulation) remains a common cause of hospitalization worldwide, but appropriate treatment is not always clear. Dobutamine improves symptoms but has been associated with an increased risk of death and other cardiovascular events, according to background information in the article. In a previous study, secondary analyses indicated that the drug levosimendan was associated with lower risk of death compared to dobutamine.

Alexandre Mebazaa, M.D., Ph.D., of the Universit Paris Diderot and Hospital Lariboisire AP-HP, Paris, and colleagues with the SURVIVE trial (Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support) conducted a study in which the primary purpose of the trial was to assess long-term survival outcomes for 1,327 ADHF patients who received levosimendan or dobutamine. The trial was conducted at 75 centers in 9 countries and patients were randomized between March 2003 and December 2004. Patients received either intravenous levosimendan (n = 664) or intravenous dobutamine (n = 663).

The researchers found that during the 180 days after drug infusion, there were 173 deaths (26 percent) in the levosimendan group and 185 deaths in the dobutamine group (28 percent). There were no statistical differences between treatment groups for most secondary end points (all-cause death at 31 days, number of days alive and out of the hospital, patient global assessment, patient assessment of dyspnea (difficulty breathing) at 24 hours, and cardiovascular death at 180 days). Compared with dobutamine-treated patients, levosimendan-treated patients were less likely to expe
'"/>

Contact: Katherine Morales
214-648-3404
JAMA and Archives Journals
1-May-2007


Page: 1 2

Related medicine news :

1. Drug-eluting stent controversy explored in the American Heart Hospital Journal
2. Heart-failure patients benefit from pharmacist care
3. Study offers clues to Broken Heart Syndrome
4. Heart Failure 2007
5. UCLA neurologist honored with American Heart Associations Stroke Council Award
6. Heart failure: Mayo Clinic reveals abnormality in filling of the heart is frequent culprit
7. Heart catheters do not benefit patients
8. Heart Rhythm Society publishes final recommendations for heart patients
9. Heartburn drug may help to slow progression of chronic heart failure
10. Heart failure drugs may be beneficial for patients with hardening of the arteries
11. University of Kentucky Gill Heart researchers study abdominal aortic aneurysms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... 02, 2020 , ... Columbia Southern University (CSU), a leading ... to Eric Simmons of Temecula, California. , CSU’s occupational safety and health ... master’s degree in occupational safety and health from the university, is the corporate ...
(Date:7/2/2020)... Conn. (PRWEB) , ... July 02, 2020 , ... ... of many businesses, including dental offices for non-emergency work. In conjunction with the ... reopening guidelines for Connecticut dental practices in mid-May. , Due to safety ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... terpenes, has officially released its new terpene infused product line including custom ... consumers to enjoy cannabis terpene profiles and flavors worldwide. , “We’ve made it ...
(Date:7/1/2020)... , ... July 01, 2020 , ... ... Doug Salvador, MD, Associate Professor of Medicine at the University of Massachusetts Medical ... Safety Strategies, LLC have joined the SIDM Board of Directors. Dr. Salvador and ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Pool & ... and redesignation of the ANSI/APSP/ICC-7 2013 American National Standard for Suction Entrapment Avoidance ... seeking member participation on the PHTA-7 Standard Writing Committee (SWC) for Suction Entrapment ...
Breaking Medicine News(10 mins):
(Date:6/25/2020)... YORK (PRWEB) , ... June 25, 2020 , ... ... by leading industry analysts Top App Developers & DesignRush following the launch a ... the first comprehensive exercise/community platform for cancer survivors. , Commissioned by ...
(Date:6/25/2020)... (PRWEB) , ... June 25, 2020 , ... The Heritage ... have had zero cases of COVID-19. With over 100,000 positive cases of the coronavirus ... the senior citizens who reside at The Heritage Downtown, their family members, as well ...
(Date:6/25/2020)... , ... June 25, 2020 , ... ... Ophthalmologist, Medford, Oregon , https://www.voiceamerica.com/episode/124183/immunity-protector-with-natures-tears-eyemist , “Eyes are our number ... World Talk Radio & Apple iTunes. “Being able to see clearly is being ...
Breaking Medicine Technology:
Cached News: